Literature DB >> 24933515

Coronary artery bypass graft: why is the saphenous vein prone to intimal hyperplasia?

Swastika Sur1, Jeffrey T Sugimoto, Devendra K Agrawal.   

Abstract

Proliferation and migration of smooth muscle cells and the resultant intimal hyperplasia cause coronary artery bypass graft failure. Both internal mammary artery and saphenous vein are the most commonly used bypass conduits. Although an internal mammary artery graft is immune to restenosis, a saphenous vein graft is prone to develop restenosis. We found significantly higher activity of phosphatase and tensin homolog (PTEN) in the smooth muscle cells of the internal mammary artery than in the saphenous vein. In this article, we critically review the pathophysiology of vein-graft failure with detailed discussion of the involvement of various factors, including PTEN, matrix metalloproteinases, and tissue inhibitor of metalloproteinases, in uncontrolled proliferation and migration of smooth muscle cells towards the lumen, and invasion of the graft conduit. We identified potential target sites that could be useful in preventing and (or) reversing unwanted consequences following coronary artery bypass graft using saphenous vein.

Entities:  

Keywords:  PTEN; coronary artery bypass graft; hyperplasie de l’intima; intimal hyperplasia; maladie du greffon veineux; matrix metalloproteinases; métalloprotéases de la matrice; pontage coronarien; vein-graft disease

Mesh:

Substances:

Year:  2014        PMID: 24933515     DOI: 10.1139/cjpp-2013-0445

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  8 in total

Review 1.  Review of Polymeric Biomimetic Small-Diameter Vascular Grafts to Tackle Intimal Hyperplasia.

Authors:  Rumbidzai Zizhou; Xin Wang; Shadi Houshyar
Journal:  ACS Omega       Date:  2022-06-21

2.  Adiponectin Prevents Restenosis Through Inhibiting Cell Proliferation in a Rat Vein Graft Model.

Authors:  Yang Zhou; Chun Dai; Bing Zhang; Jianjun Ge
Journal:  Arq Bras Cardiol       Date:  2021-12       Impact factor: 2.667

3.  Can We Pretreat Vein Grafts with Adiponectin to Improve Their Patency?

Authors:  Maria Cristina de Oliveira Izar; Francisco A H Fonseca
Journal:  Arq Bras Cardiol       Date:  2021-12       Impact factor: 2.667

4.  Collagen External Scaffolds Mitigate Intimal Hyperplasia and Improve Remodeling of Vein Grafts in a Rabbit Arteriovenous Graft Model.

Authors:  Haiming Li; Shoudong Chai; Longsheng Dai; Chengxiong Gu
Journal:  Biomed Res Int       Date:  2017-04-19       Impact factor: 3.411

5.  Rapamycin Combined with α-Cyanoacrylate Contributes to Inhibiting Intimal Hyperplasia in Rat Models.

Authors:  Jianjun Ge
Journal:  Arq Bras Cardiol       Date:  2018-12-17       Impact factor: 2.000

6.  Increased Expression of Phosphorylated Polo-Like Kinase 1 and Histone in Bypass Vein Graft and Coronary Arteries following Angioplasty.

Authors:  Swastika Sur; Vicki J Swier; Mohamed M Radwan; Devendra K Agrawal
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

7.  Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.

Authors:  Yongxin Sun; Le Kang; Jun Li; Huan Liu; Yulin Wang; Chunsheng Wang; Yunzeng Zou
Journal:  J Cell Mol Med       Date:  2016-06-14       Impact factor: 5.310

8.  Atorvastatin Reduces Accumulation of Vascular Smooth Muscle Cells to Inhibit Intimal Hyperplasia via p38 MAPK Pathway Inhibition in a Rat Model of Vein Graft.

Authors:  Tianshu Chu; Molin Huang; Zhiwei Zhao; Fei Ling; Jing Cao; Jianjun Ge
Journal:  Arq Bras Cardiol       Date:  2020-10       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.